Literature DB >> 15912289

Detection of circulating cancer cells after a gastrectomy for gastric cancer.

Masahide Ikeguchi1, Nobuaki Kaibara.   

Abstract

PURPOSE: In this study, we evaluated the correlation between the postoperative detection of circulating cancer cells and the risk of recurrence in patients with gastric cancer.
METHODS: Total RNA was extracted from 1.5 ml of peripheral blood from 59 patients with gastric cancer and 15 patients with cholecystolithiasis (control) before and after operation. Carcinoembryonic antigen (CEA) messenger RNA (mRNA) was used as a probe to detect gastric cancer cells in samples using a real-time reverse transcription-polymerase chain reaction (RT-PCR).
RESULTS: Carcinoembryonic antigen mRNA-positive cells were not found in the peripheral blood of the control patients either before or after operation, nor in the peripheral blood of the gastric cancer patients before operation. However, CEA and mRNA-positive cells were detected in 46% of the patients just after a gastrectomy, though these circulating cancer cells disappeared from peripheral blood within 2 postoperative days. In 55 patients who underwent a curative operation, the risk for cancer recurrence (10/30; 33%) in 30 patients who did not show circulating cancer cells postoperatively was higher than that for cancer recurrence (3/25; 12%) in 25 patients with positive for circulating cancer cells (P = 0.064). As a result, the presence of blood circulating tumor cells just after surgery tends to correlate with a low rate of tumor recurrence in patients operated on for gastric cancer.
CONCLUSION: These findings indicate that a gastrectomy may spread gastric cancer cells into the peripheral blood from primary tumors; however, such circulating cancer cells may be destroyed within a short time. The detection of circulating cancer cells may therefore be a marker for a possibly better prognosis in patients with gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15912289     DOI: 10.1007/s00595-004-2978-z

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  18 in total

1.  Identification of novel molecular markers for detection of gastric cancer cells in the peripheral blood circulation using genome-wide microarray analysis.

Authors:  Nobuyuki Matsumura; Hitoshi Zembutsu; Koji Yamaguchi; Kazuaki Sasaki; Tetsuhiro Tsuruma; Toshihiko Nishidate; Ryuichi Denno; Koichi Hirata
Journal:  Exp Ther Med       Date:  2011-04-08       Impact factor: 2.447

Review 2.  Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance.

Authors:  Yun-Fan Sun; Xin-Rong Yang; Jian Zhou; Shuang-Jian Qiu; Jia Fan; Yang Xu
Journal:  J Cancer Res Clin Oncol       Date:  2011-06-17       Impact factor: 4.553

3.  Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications.

Authors:  Georg Lurje; Marc Schiesser; Andreas Claudius; Paul Magnus Schneider
Journal:  J Oncol       Date:  2009-11-05       Impact factor: 4.375

Review 4.  Recent results of therapy for scirrhous gastric cancer.

Authors:  Masahide Ikeguchi; Takanori Miyake; Tomoyuki Matsunaga; Manabu Yamamoto; Youji Fukumoto; Yosinori Yamada; Kenji Fukuda; Hiroaki Saito; Shigeru Tatebe; Shun-ichi Tsujitani
Journal:  Surg Today       Date:  2009-03-25       Impact factor: 2.549

Review 5.  Liquid biopsy of gastric cancer patients: circulating tumor cells and cell-free nucleic acids.

Authors:  Masahiro Tsujiura; Daisuke Ichikawa; Hirotaka Konishi; Shuhei Komatsu; Atsushi Shiozaki; Eigo Otsuji
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

6.  Clinical significance of circulating tumor cell related markers in patients with epithelial ovarian cancer before and after adjuvant chemotherapy.

Authors:  Meysam Yousefi; Sara Rajaie; Vahideh Keyvani; Somayeh Bolandi; Malihe Hasanzadeh; Alireza Pasdar
Journal:  Sci Rep       Date:  2021-05-18       Impact factor: 4.379

Review 7.  Diagnostic accuracy of circulating tumor cells detection in gastric cancer: systematic review and meta-analysis.

Authors:  Lanhua Tang; Shushan Zhao; Wei Liu; Nicholas F Parchim; Jin Huang; Youhong Tang; Pingping Gan; Meizuo Zhong
Journal:  BMC Cancer       Date:  2013-06-27       Impact factor: 4.430

8.  Detection of carcinoembryonic antigen messenger RNA in blood using quantitative real-time reverse transcriptase-polymerase chain reaction to predict recurrence of gastric adenocarcinoma.

Authors:  Miao-Zhen Qiu; Zhuang-Hua Li; Zhi-Wei Zhou; Yu-Hong Li; Zhi-Qiang Wang; Feng-Hua Wang; Peng Huang; Fahad Aziz; Dao-Yuan Wang; Rui-Hua Xu
Journal:  J Transl Med       Date:  2010-10-31       Impact factor: 5.531

9.  Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases.

Authors:  Y Kita; T Fukagawa; K Mimori; Y Kosaka; K Ishikawa; T Aikou; S Natsugoe; M Sasako; M Mori
Journal:  Br J Cancer       Date:  2008-12-02       Impact factor: 7.640

10.  Analysis of circulating hem-endothelial marker RNA levels in preterm infants.

Authors:  Tzipora Strauss; Sally Metsuyanim; Itai Pessach; Irit Shuchan-Eisen; Jacob Kuint; Benjamin Dekel
Journal:  BMC Pediatr       Date:  2009-06-25       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.